Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News. Citius Pharma (CTXR) Inches Closer to the Next Phase III Data Announcement. Citius Pharma Presenting at...
Citius, Biotech Stock Review

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial

PHASE III PROGRESS October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019 - Data Analysis Back, Results Positive.February...

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy interim analysis should represent the next...
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $4.00 (from $1.65) while maintaining a Buy rating. The analyst commented,...
coronavirus, biotech stock review

VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop the spread of coronavirus and to...

Stand Down V: MAGA. Each Crossing $1 Trillion, Microsoft, Amazon, Google, and AAPL.

Is this today's version of the Nifty 50? Microsoft $1.3 Trillion Apple $1.3 Trillion Google $1 Trillion Amazon $1 Trillion Biotech Stock Review: Biotech 5 Pack. 5 Biotech Stocks...

CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).

INITIAL WATCHLIST: CoronaVirus Watch List | Superbug Stock Review Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40   Alpha Pro Tech, Ltd. (NYSE: APT) $6.00AstraZeneca plc (NYSE: AZN) $49BioCryst Pharmaceuticals, Inc.'s (NASDAQ: BCRX) $2.80  Cerus Corporation (NASDAQ: CERS)...
Immunomedics, Biotech Stock Review

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite Biotech stocks that have the potential to...
Citius Pharmaceutical, CTXR, Biotech Stock Review

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the Biotech Stock...

Citius Pharma (CTXR) Corporate Presentation (Jan 2020).

In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic below) at...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...